The following was published on 14 December by Univadis, an organisation linked to Medscape, that provides information primarily for medical professionals. It is interesting to see a medical-based organisation reporting on an initiative instigated by CAM professionals
A major new international campaign is being launched to promote the widespread use of vitamin C wherever there is an increased risk of COVID-19 infection, as well as an additional treatment for those with severe infection.
The launch of vitaminC4covid.com follows the publication of a major review of over 100 trials of the vitamin and the virus, which concluded that oral vitamin C (2-8 g/day) may reduce the incidence and duration of respiratory infections and intravenous vitamin C (6-24 g/day) appears to reduce mortality, intensive care unit (ICU) admission, hospital stays, and time on mechanical ventilation.
Already 20 medical and nutritional organisations from 49 countries are supporting the campaign. Over 5,000 doctors, nutritionists, health scientists and members of the public have joined the campaign.
There are currently 45 trials registered using vitamin C around the world. The evidence is already considerably more substantial than that for vitamin D, another key COVID 19 defence nutrient.
The aim of the vitaminC4covid.com is to get vitamin C taken seriously, both by governments, healthcare systems and individuals around the world.
The campaign is calling for widespread vitamin C testing with a urine dip stick for those vulnerable to COVID-19.
References Holford P, Carr AC, Jovic TH, Ali SR, Whitaker IS, Marik PE, Smith AD. Vitamin C-An Adjunctive Therapy for Respiratory Infection, Sepsis and COVID-19. Nutrients. 2020 Dec 7;12(12):E3760. doi: 10.3390/nu12123760. PMID: 33297491.